3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Breast Neoplasms
145
Neoplasm Metastasis
16
Advanced Breast Cancer
9
Neoplasms
8
Ovarian Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Breast Cancer Metastatic
5
Prostatic Neoplasms
4
Endometrial Neoplasms
4
Recurrence
3
Hereditary Sensory and Autonomic Neuropathies
3
Lung Neoplasms
2
Hyperglycemia
2
Exanthema
2
Estrogen Receptor-positive Breast Cancer
2
Colorectal Neoplasms
2
Carcinoma, Lobular
2
Breast Neoplasms, Male
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sex Cord-Gonadal Stromal Tumors
1
Sarcoma, Endometrial Stromal
1
Salivary Gland Neoplasms
1
Recurrent Uterine Corpus Carcinoma
1
Neoplastic Cells, Circulating
1
Interventions
trebananib
1
selurampanel
1
saracatinib
1
perifosine
1
elacestrant
1
Trabectedin
1
Thalidomide
1
Temozolomide
1
Sunitinib
1
RAD1901
1
Postmortem Imaging
1
Paclitaxel
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Injections
1
Imatinib Mesylate
1
Ifosfamide
1
High-Energy Shock Waves
1
Fulvestrant
1
Doxorubicin
1
Chromatography, High Pressure Liquid
1
Biopsy
1
BI 2536
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Sarcoma, Endometrial Stromal
×
Fulvestrant
×
Clear all
NCT03926936
2024-05-28
FUCHSia
University Hospital, Gasthuisberg
Phase 2
Completed
17 enrolled